LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+10.46%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.06B
AUM Growth
+$1.06B
(+15%)
Cap. Flow
+$69.2M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
25.06%
Holding
408
New
56
Increased
139
Reduced
102
Closed
42
Top Buys
| 1 |
Cigna
CI
|
$26.1M |
| 2 |
Pfizer
PFE
|
$19.4M |
| 3 |
Morgan Stanley
MS
|
$16.2M |
| 4 |
Mastercard
MA
|
$12.9M |
| 5 |
Halozyme
HALO
|
$10.6M |
Top Sells
| 1 |
Amazon
AMZN
|
$17.2M |
| 2 |
Elevance Health
ELV
|
$13.5M |
| 3 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
$12M |
| 4 |
Home Depot
HD
|
$10.1M |
| 5 |
Alibaba
BABA
|
$8.04M |
Sector Composition
| 1 | Healthcare | 32.52% |
| 2 | Consumer Discretionary | 16.47% |
| 3 | Financials | 13.41% |
| 4 | Technology | 7.88% |
| 5 | Consumer Staples | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$322B
| $47.7M | 4.49% | 225,125 -37,900 | -14% | -$8.04M |
|
2
Visa
V
$683B
| $28.9M | 2.71% | 153,660 +5,585 | +4% | +$1.05M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $27.8M | 2.61% | 145,498 +23,825 | +20% | +$4.55M |
|
|
4
Cigna
CI
$80.3B
| $26.6M | 2.5% | 130,190 +127,794 | +5,334% | +$26.1M |
|
5
Lowe's Companies
LOW
$145B
| $25.6M | 2.41% | 213,945 +70,353 | +49% | +$8.43M |
|
6
Zoetis
ZTS
$69.3B
| $25M | 2.35% | 188,998 | – | – |
|
7
Medtronic
MDT
$119B
| $22.4M | 2.1% | 197,097 -29,084 | -13% | -$3.3M |
|
8
Service Corp International
SCI
$11.1B
| $20.7M | 1.95% | 450,000 -30,000 | -6% | -$1.38M |
|
|
9
Pfizer
PFE
$141B
| $20.6M | 1.94% | 526,907 +494,668 | +1,534% | +$19.4M |
|
10
Apollo Global Management
APO
$77.9B
| $20M | 1.88% | 420,000 +40,000 | +11% | +$1.91M |
|
11
Abbott
ABT
$231B
| $20M | 1.88% | 230,071 -33,332 | -13% | -$2.9M |
|
12
Boston Scientific
BSX
$156B
| $19.2M | 1.8% | 424,321 | – | – |
|
13
Baxter International
BAX
$12.7B
| $17.9M | 1.69% | 214,574 -62,993 | -23% | -$5.27M |
|
14
Equity Lifestyle Properties
ELS
$11.7B
| $17.6M | 1.65% | 250,000 +95,000 | +61% | +$6.69M |
|
15
Stryker
SYK
$150B
| $16.7M | 1.57% | 79,543 -25,813 | -25% | -$5.42M |
|
16
UnitedHealth
UNH
$281B
| $16.7M | 1.57% | 56,757 +402 | +0.7% | +$118K |
|
|
17
Morgan Stanley
MS
$240B
| $16.5M | 1.55% | 323,698 +316,133 | +4,179% | +$16.2M |
|
18
Humana
HUM
$36.5B
| $16M | 1.51% | 43,787 +3,106 | +8% | +$1.14M |
|
|
19
Halozyme
HALO
$8.56B
| $16M | 1.5% | 900,000 +600,000 | +200% | +$10.6M |
|
20
Pool Corp
POOL
$11.6B
| $15.9M | 1.5% | 75,000 | – | – |
|
21
Estee Lauder
EL
$33B
| $15.3M | 1.43% | 73,948 +28,557 | +63% | +$5.9M |
|
22
Yum China
YUMC
$16.4B
| $14.8M | 1.39% | 308,895 +9,360 | +3% | +$449K |
|
23
Thermo Fisher Scientific
TMO
$186B
| $14.7M | 1.38% | 45,246 -18,877 | -29% | -$6.13M |
|
24
Ambev
ABEV
$34.9B
| $14.3M | 1.34% | 3,067,700 -813,800 | -21% | -$3.79M |
|
25
Merck
MRK
$210B
| $14.3M | 1.34% | 156,949 +15,791 | +11% | +$1.44M |
|